Jenkem Technology Future Growth
Future criteria checks 5/6
Jenkem Technology is forecast to grow earnings and revenue by 28% and 21.6% per annum respectively. EPS is expected to grow by 27.8% per annum. Return on equity is forecast to be 13.7% in 3 years.
Key information
28.0%
Earnings growth rate
27.8%
EPS growth rate
Pharmaceuticals earnings growth | 19.3% |
Revenue growth rate | 21.6% |
Future return on equity | 13.7% |
Analyst coverage | Low |
Last updated | 20 Mar 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 461 | 216 | N/A | N/A | 1 |
12/31/2024 | 363 | 161 | N/A | N/A | 1 |
12/31/2023 | 299 | 123 | N/A | N/A | N/A |
9/30/2023 | 331 | 122 | -46 | 108 | N/A |
6/30/2023 | 364 | 144 | -48 | 146 | N/A |
3/31/2023 | 399 | 182 | -58 | 180 | N/A |
12/31/2022 | 407 | 187 | -27 | 186 | N/A |
9/30/2022 | 410 | 199 | -4 | 197 | N/A |
6/30/2022 | 410 | 207 | 24 | 214 | N/A |
3/31/2022 | 382 | 192 | 0 | 157 | N/A |
12/31/2021 | 351 | 176 | -47 | 118 | N/A |
9/30/2021 | 323 | 172 | 55 | 160 | N/A |
6/30/2021 | 277 | 139 | 38 | 99 | N/A |
3/31/2021 | 230 | 111 | 45 | 87 | N/A |
12/31/2020 | 187 | 86 | 60 | 78 | N/A |
9/30/2020 | 167 | 77 | 42 | 63 | N/A |
6/30/2020 | 148 | 70 | 46 | 69 | N/A |
3/31/2020 | 139 | 66 | 15 | 38 | N/A |
12/31/2019 | 134 | 62 | 29 | 51 | N/A |
12/31/2018 | 101 | 36 | 26 | 34 | N/A |
12/31/2017 | 77 | 21 | 13 | 21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688356's forecast earnings growth (28% per year) is above the savings rate (2.9%).
Earnings vs Market: 688356's earnings (28% per year) are forecast to grow faster than the CN market (27% per year).
High Growth Earnings: 688356's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688356's revenue (21.6% per year) is forecast to grow faster than the CN market (15.2% per year).
High Growth Revenue: 688356's revenue (21.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688356's Return on Equity is forecast to be low in 3 years time (13.7%).